Palo Alto, CA, United States of America

Mark Solloway


Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Solloway: Innovator in Antibody Development

Introduction

Mark Solloway is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, Solloway's work focuses on innovative solutions that address complex biological challenges.

Latest Patents

Solloway's latest patents include the invention of anti-LRP6 antibodies. This invention provides anti-LRP6 antibodies and methods of using them. A particular aspect of this invention features bispecific anti-LRP6 antibodies that inhibit signaling by multiple Wnt isoforms. This advancement has the potential to impact various therapeutic applications.

Career Highlights

Mark Solloway is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry.

Collaborations

Some of his notable coworkers include Eric Bourhis and Rick Carano. Their collective expertise contributes to the advancement of research and development in the field of biotechnology.

Conclusion

Mark Solloway's contributions to the field of antibody development exemplify the spirit of innovation in biotechnology. His work continues to pave the way for new therapeutic solutions that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…